# Raritan Pharmaceuticals, Inc. – FDA Inspection, Jan 8, 2018

Source: https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/f275a0be-8cda-446f-9c15-5566f69959dc
Source feed: FDA_Inspections

> FDA inspection 1037112 of Raritan Pharmaceuticals, Inc., January 08, 2018. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1037112
- Company Name: Raritan Pharmaceuticals, Inc.
- Inspection Date: 2018-01-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1250227 - 2025-04-02](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/1a844f99-5473-4890-a8bf-2c8de0080187)
- [FDA Inspection 995165 - 2016-10-20](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/779fe977-f104-48a2-84ec-2f8ccae976e3)
- FDA Inspection 969785 - 2016-04-14
- [FDA Inspection 799355 - 2012-09-19](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/af765194-be49-48aa-836e-424e9af61645)
- [FDA Inspection 798953 - 2012-08-21](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/03248a1a-d694-4d0b-b656-3e883d512301)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)

Company: https://www.keypedia.com/companies/raritan-pharmaceuticals-inc/31d76ce5-e5b2-4f61-b7b5-daa1a81f7cf0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c